Regardless of the challenges a smaller group might have, a risk assessment is a baseline for any HIPAA program. The cost of this assessment is considerably less than a HIPAA fine.
A panel prepared a comprehensive set of practice implications for clinicians caring for adults with acute ischemic stroke with confirmed or suspected of having COVID-19.
Biota Biosciences announced the voluntary recall of CBD Complex, Curcumin Complex, and Cannabidiol + Curcumin Injectables due to the products being marketed without the approval of the FDA.
Precision medicine offers a promising therapeutic strategy for patients with Parkinson disease, allowing for tailored treatments which reflect the unique pathophysiology in each patient.
In light of the changes inflicted by the COVID-19 pandemic, the researchers wished to explore the effects of the pandemic on stroke management during the first month of Italy’s lockdown.
